Observing ozonated water's effectiveness against SARS-CoV-2 in saliva
Disinfecting surfaces is crucial in keeping bacteria and viruses at bay, but the cleaning solutions could be ineffective if ...
Grays Harbor Daily News23h
Optimum Digestion Plus Claims to Fix Your Digestion Naturally—But Is It Worth the Hype?
In today’s fast-paced world, maintaining optimal digestive health is more crucial than ever. Many individuals struggle with ...
Armed robbery in Revesby5d
Ozonated Water Tested Against Covid in Saliva
Disinfecting surfaces is crucial in keeping bacteria and viruses at bay, but the cleaning solutions could be ineffective if ...
Hosted on MSN1d
The Surprising Reason You Shouldn't Double Dip (It's Not Just Germs)
Nobody seemed to know for sure, but every once in a while someone in the discussion would float a suggestion that made ...
Endocrinology Advisor24d
Risk for Pancreatitis Does Not Increase With Tirzepatide
Although tirzepatide use was associated with elevated amylase and lipase levels, risk for pancreatitis was not elevated among users of tirzepatide vs placebo. Tirzepatide does not yield a significant ...
The New England Journal of Medicine5d
Parotid Swelling, Alcoholism and Cirrhosis
The serum amylase was elevated in 1 other patient who did not have pancreatitis clinically; permission for autopsy was not obtained. None of the patients were aware of the enlargement of the ...
Eating Too Quickly? Here's How It Impacts Your Digestion And Health
Eating quickly often leads to poor chewing, which allows larger food particles to pass into the stomach. It causes indigestion, bloating, and imprecise nutritional extraction by placing more pressure ...
Morningstar23d
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvoâ„¢ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
– Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drivers of inflammation and fibrosis – – Pivotal data from the AGAVE-201 trial ...
Medindia24d
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvoâ„¢ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
– Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drivers of inflammation and fibrosis – WILMINGTON, Del. and WALTHAM, Mass., Jan. 15, 2025 ...